Top 20 reports

1. Bitopertin for schizophrenia: primary, persistent negative symptoms; sub-optimally controlled positive symptoms – in combination with antipsychotics - Jun  2012

2. Aflibercept (Eylea) for visual impairment due to diabetic macular oedema – first line - Jun  2013

3. ExAblate® Neuro MR guided focused ultrasound for Parkinson’s disease, essential tremor and neuropathic pain - Mar  2013

4. Liraglutide for obesity or overweight in patients with associated co-morbidities - Oct  2013

5. BreathLink™ for breast cancer screening - Jan  2014

6. Strokefinder MD100 microwave tomography for early diagnosis of stroke type - Mar  2014

7. ATI™ Neurostimulation System for cluster headache - Nov  2013

8. Asfotase alfa for hypophosphatasia - Dec  2013

9. SmartSensor electronic oral glucose tolerance test for screening for diabetes - Dec  2013

10. Ellex 2RT™ for early age-related macular degeneration - Nov  2013

11. Sofosbuvir with ledipasvir for hepatitis C, genotype 1 - Aug  2013

12. Curodont™ Repair and Curodont Protect™ for the treatment and prevention of tooth decay - Jul  2013

13. LCQ908 (Pradigastat) for familial chylomicronaemia syndrome – first line - Aug  2013

14. Idelalisib with rituximab for chronic lymphocytic leukaemia - Jul  2013

15. Etanercept (Enbrel) for axial spondyloarthritis without radiographic evidence of ankylosing spondylitis - Oct  2013

16. Macula Risk PGx test for dry age-related macular degeneration - Sep  2013

17. Ibrutinib for relapsed or refractory chronic lymphocytic leukaemia – second and subsequent line - Jul  2013

18. Abraxane in combination with gemcitabine for metastatic pancreatic cancer – first line - Jan  2013

19. Efraloctocog alfa (Eloctate) for haemophilia A in adults and children - Oct  2013

20. Lubiprostone (Amitiza) for chronic idiopathic constipation - Aug  2012

Pause Ticker Next Item Previous Item

What’s new on the site

View all outputs

Latest news articles


Latest pharmacological technology briefings now available

Our latest batch of briefings on pharmacological technologies in development is now available. These include briefings in the following sp...

Latest briefings on pharmacological technologies for the treatment of cancer

Our latest batch of briefings on pharmacological technologies in development for the treatment of cancer is now available. These include: ...

Latest Medtech Alerts

The following Medtech Alerts on innovative new and emerging medical devices and diagnostics have recently been uploaded to our website: Sh...

New leadless pacing systems on the horizon

While conventional pacemakers are overall safe and effective, the device leads, or wires that are implanted into the heart, can cause comp...

What’s coming in incontinence?

We have published the latest in our series of reports about what’s in development for specific condition – this time incontinence (both ur...

View all articles

Join Our Mailing list

Our regular newsletter contains a quick roundup of the latest news, briefings and reports on Horizon Scanning

Follow us on Twitter

The NIHR Horizon Scanning Offices will be closed from 5pm this evening - back in the office next Thursday 24th April. Happy Easter to all

Apr 17, 2014, 1:46 pm